LEXICON GENETICS, INCORPORATED

Company

LEXICON PHARMACEUTICALS, INC.

Filed

April 5, 2002

Period of Report

May 8, 2002

Accession Number

0000950129-02-001776

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →